Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125172423 | 12517242 | 3 | F | 20160802 | 20160630 | 20160805 | EXP | AU-PFIZER INC-2970434 | PFIZER | KENNEDY, B. INTERACTION BETWEEN VORICONAZOLE AND FLUCLOXACILLIN DURING TREATMENT OF DISSEMINATED SCEDOSPORIUM APIOSPERMUM INFECTION. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2015;70(7):2171-2173 | 8.00 | DEC | M | Y | 0.00000 | 20160805 | OT | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125172423 | 12517242 | 1 | I | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Intravenous (not otherwise specified) | 2 G FOUR TIMES A DAY | 0 | 2 | G | QID | |||||||
125172423 | 12517242 | 2 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | INITIAL LOADING DOSE AND FROM DAY 38 TO DAY 46 | 21266 | POWDER FOR INJECTION | |||||||||
125172423 | 12517242 | 3 | I | VORICONAZOLE. | VORICONAZOLE | 1 | Oral | UNK | 21266 | POWDER FOR INJECTION | |||||||||
125172423 | 12517242 | 4 | C | DOCUSATE W/SENNOSIDE A+B | 2 | UNK | 0 | ||||||||||||
125172423 | 12517242 | 5 | C | MAGNESIUM W/POTASSIUM | 2 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125172423 | 12517242 | 1 | Staphylococcal infection |
125172423 | 12517242 | 2 | Scedosporium infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125172423 | 12517242 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125172423 | 12517242 | Antibiotic level below therapeutic | |
125172423 | 12517242 | Drug interaction | |
125172423 | 12517242 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |